Review paper

Novel Pathways in the Treatment of Major Depression: Focus on the Glutamatergic System

Volume: 25, Issue: 4, Pages: 381 - 387
Published: Jun 3, 2019
Abstract
Depressive disorders represent protean psychiatric illnesses with heterogeneous clinical manifestations and a multitude of comorbidities leading to severe disability. In spite of decades of research on the pathophysiogenesis of these disorders, the wide variety of pharmacotherapies currently used to treat them is based on the modulation of monoamines, whose alteration has been considered the neurobiological foundation of depression, and...
Paper Details
Title
Novel Pathways in the Treatment of Major Depression: Focus on the Glutamatergic System
Published Date
Jun 3, 2019
Volume
25
Issue
4
Pages
381 - 387
Citation AnalysisPro
  • Scinapse’s Top 10 Citation Journals & Affiliations graph reveals the quality and authenticity of citations received by a paper.
  • Discover whether citations have been inflated due to self-citations, or if citations include institutional bias.